Previous studies have suggested that clozapine may improve neuropsychological test performance. The current study was designed to examine the comparative efficacy and the long-term effect of clozapine (versus haloperidol), on neuropsychological test performance. Neuropsychological measures of executive/attention, visuospatial, and memory function were administered to schizophrenic patients at baseline, at the end of a 10-week double-blind study, and after 1 year of open clozapine treatment. Symptoms and function ratings were obtained at the same time points. The 10-week double-blind study revealed significant group-by-time interactions for two measures: Categorical Fluency and WAIS-R Block Design. At the end of 1 year of open treatment there were significant improvements in Verbal Fluency, Mooney Faces Closure, and WAIS-R Block Design performance, and trend improvements in Stroop Color-Word Interference, Category Fluency, and WMS-R Logical Memory performance. Improvements in neuropsychological performance were unrelated to symptom changes. Change in selected neuropsychological measures were significantly correlated with improvement in quality of life. The results suggest that long-term clozapine treatment may have beneficial effects on a broad range of cognitive functions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0006-3223(94)90082-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Early postnatal NMDA receptor ablation in cortical interneurons impairs affective state discrimination and social functioning.
Neuropsychopharmacology
January 2025
Grupo de Neurociencia de Sistemas, Departamento de Ciencias Fisiológicas, Facultad de Ciencias Médicas, Universidad de Buenos Aires, Buenos Aires, Argentina.
Emotion recognition is fundamental for effective social interactions among conspecifics. Impairments in affective state processing underlie several neuropsychiatric disorders, including schizophrenia, although the neurobiological substrate of these deficits remains unknown. We investigated the impact of early NMDA receptor hypofunction on socio-affective behaviors.
View Article and Find Full Text PDFRisk of agranulocytosis and neutropenia in patients with Parkinson's disease psychosis receiving clozapine treatment: A systematic review and meta-analysis.
Gen Hosp Psychiatry
January 2025
Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Electronic address:
Objective: To assess the cumulative incidence of severe neutropenia and agranulocytosis (SNA) and mild and moderate neutropenia (MMN) in patients with Parkinson's disease psychosis (PDP) who receive clozapine treatment.
Methods: We searched multiple databases to identify clozapine studies in PDP patients. Incidence rates were assessed during short-term (within 1 month), medium-term (within 6 months), and long-term (> 6 months) monitoring periods.
Genetic identification of undiagnosed benign ethnic neutropenia in patients receiving clozapine treatment.
Br J Psychiatry
December 2024
Institute of Pharmaceutical Sciences, King's College London, UK; and Pharmacy Department, South London and Maudsley NHS Foundation Trust, London, UK.
Article Synopsis
- Clozapine therapy can lead to agranulocytosis, which requires monitoring of white blood cell counts, and it's crucial to identify benign ethnic neutropenia (BEN) to avoid unnecessary clozapine withdrawal.
- * A study introduced voluntary genetic testing for BEN in a clozapine clinic to determine how many patients had undiagnosed BEN, finding that 24% of participants were newly diagnosed with this condition.
- * Results showed that undiagnosed BEN was common among patients, suggesting that adding genetic testing to regular monitoring could improve clozapine therapy management and enable safe continuation for those with unrecognized BEN.
Use and discontinuation of antipsychotic medication in 20 years following a first episode of schizophrenia: results from the OPUS trial.
Psychol Med
November 2024
Copenhagen Research Centre for Mental Health - CORE, Mental Health Center Copenhagen, Mental Health Services in the Capital Region, Hellerup, Denmark.
Introduction: Short-term exposure to antipsychotics has proven to be beneficial. However, naturalistic studies are lacking regarding the long-term use of antipsychotics. This study aimed to investigate changes in use of antipsychotics over 20 years after a first-episode schizophrenia.
View Article and Find Full Text PDFA Simple HPLC-DAD Method for the Therapeutic Monitoring of Clozapine and Related Metabolites in Human Plasma and Urine Samples.
Molecules
October 2024
Department of Analytical & Physical Chemistry, Faculty of Chemistry, University of Bucharest, Panduri Ave. # 90-92, 050663 Bucharest, Romania.
Clozapine and its metabolites require close therapeutic monitoring (TDM) in patients due to poor correlation between the administrated doses and resulting plasma concentrations, the narrow therapeutic interval, high inter-individual variability, and the risk of serious side effects once toxic levels are exceeded. The aim of the study was to develop a simple (relatively cheap) LC-UV method for the quantification of clozapine and its metabolites in plasma and urine samples. For sample preparation, liquid-liquid extraction (LLE) in -octanol was more efficient and less limiting in injection volumes compared to the in-situ formation of SUPRAS.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!